Fabio P. Nunes
Pediatric Hematology Oncology
705 Riley Hospital Dr
Roc 4340
Indianapolis, IN 46202
Roc 4340
Indianapolis, IN 46202
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.
Journal: The New England journal of medicine
Published: November 05, 2025
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites.
Journal: NEJM evidence
Published: November 05, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Journal: Lancet (London, England)
Published: July 08, 2025
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.
Journal: The British journal of dermatology
Published: October 25, 2021
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 07, 2021
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16.
Journal: Dermatology and therapy
Published: June 21, 2021
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
Journal: JAMA dermatology
Published: May 12, 2021
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
Journal: Journal of the American Academy of Dermatology
Published: April 07, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
Journal: American journal of clinical dermatology
Published: March 26, 2021
Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
Journal: Health and quality of life outcomes
Published: January 22, 2021
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
Journal: The Journal of dermatological treatment
Published: November 23, 2020
The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
Journal: The journal of investigative dermatology. Symposium proceedings
Published: October 25, 2020
Last Updated: 09/26/2026